Low Carb Health Doctor | LCHD

Dr. Eric Westman, MD, MHS

Dr. Eric Westman is an Associate Professor of Medicine at Duke University. Board Certified in Obesity Medicine and Internal Medicine, Dr. Westman founded the Duke Lifestyle Medicine Clinic in 2006 after 8 years of clinical research on low carbohydrate & ketogenic diets.

Dr. Westman combines clinical research and clinical care to deliver lifestyle treatments for obesity, diabetes and tobacco dependence. He is an internationally known researcher specialising in low-carbohydrate nutrition and is Past-President and Master Fellow of the Obesity Medicine Association and Fellow of The Obesity Society.

Dr. Westman is also an editor of the textbook “Obesity: Evaluation & Treatment Essentials”, and author of the New York Times Bestseller “The New Atkins for a New You”, “Cholesterol Clarity”, and “Keto Clarity”. He is co-founder of the companies Adapt Your Life, and Heal Diabetes Clinics, which are based on low carbohydrate concepts.

Books by Dr. Eric Westman, MD

Video Presentations of Dr. Eric Westman, MD

Scholarly Articles from Dr. Eric Westman, MD

Books by Dr. Eric Westman, MD

Video Presentations of Dr. Eric Westman, MD

"Keto Medicine - The Practice of Carb Restriction" - Dr. Eric Westman, MD

Dr. Eric Westman is an Associate Professor of Medicine at Duke University. Board Certified in Obesity Medicine and Internal Medicine, Dr. Westman founded the Duke Lifestyle Medicine Clinic in 2006 after 8 years of clinical research on low carbohydrate & ketogenic diets.

Dr. Westman combines clinical research and clinical care to deliver lifestyle treatments for obesity, diabetes and tobacco dependence. He is an internationally known researcher specialising in low-carbohydrate nutrition and is Past-President and Master Fellow of the Obesity Medicine Association and Fellow of The Obesity Society.

Dr. Westman is also an editor of the textbook “Obesity: Evaluation & Treatment Essentials”, and author of the New York Times Bestseller “The New Atkins for a New You”, “Cholesterol Clarity”, and “Keto Clarity”. He is co-founder of the companies Adapt Your Life, and Heal Diabetes Clinics, which are based on low carbohydrate concepts.

"Evidence-based vs. Internet-based Keto" - Dr. Eric Westman, MD

20 Years Low Carb Experience with Dr. Eric Westman, MD

Few people have as much experience helping patients use a low-carb lifestyle to improve their health as Dr. Westman. He has been doing this for over 20 years, and he approaches low-carb medicine from both a research and clinical perspective. Through the years, he's shared valuable insights about the clinical utility of low-carb lifestyles.

With his extensive knowledge, he's helped thousands of patients revitalize their heath. Interested in low carb? Then here's your chance to hear a veteran practitioner share his wisdom.

"LCHF and Diabetes: Theory and Clinical Experience" - Dr. Eric Westman, MD

Dr. Eric C. Westman is an associate professor of medicine at Duke University Health System and director of the Duke Lifestyle Medicine Clinic.

Dr. Westman combines clinical research and clinical care to deliver lifestyle treatments for obesity, diabetes and tobacco dependence. He is an internationally known researcher specialising in low-carbohydrate nutrition and is co-author of 'The New Atkins For A New You', 'Keto Clarity' and 'Cholesterol Clarity'. He has also helped do several high-quality scientific studies on low carb.

Dr. Westman is currently the vice president of the American Society of Bariatric Physicians and a fellow of the Obesity Society and the Society of General Internal Medicine.

Scholarly Articles from Dr. Eric Westman, MD

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus - Nutrition & MetabolismObjective Dietary carbohydrate is the major determinant of postprandial glucose levels, and several clinical studies have shown that low-carbohydrate diets improve glycemic control. In this study, we tested the hypothesis that a diet lower in carbohydrate would lead to greater improvement in glycemic control over a 24-week period in patients with obesity and type 2 diabetes mellitus. Research design and methods Eighty-four community volunteers with obesity and type 2 diabetes were randomized to either a low-carbohydrate, ketogenic diet (<20 g of carbohydrate daily; LCKD) or a low-glycemic, reduced-calorie diet (500 kcal/day deficit from weight maintenance diet; LGID). Both groups received group meetings, nutritional supplementation, and an exercise recommendation. The main outcome was glycemic control, measured by hemoglobin A1c. Results Forty-nine (58.3%) participants completed the study. Both interventions led to improvements in hemoglobin A1c, fasting glucose, fasting insulin, and weight loss. The LCKD group had greater improvements in hemoglobin A1c (-1.5% vs. -0.5%, p = 0.03), body weight (-11.1 kg vs. -6.9 kg, p = 0.008), and high density lipoprotein cholesterol (+5.6 mg/dL vs. 0 mg/dL, p < 0.001) compared to the LGID group. Diabetes medications were reduced or eliminated in 95.2% of LCKD vs. 62% of LGID participants (p < 0.01). Conclusion Dietary modification led to improvements in glycemic control and medication reduction/elimination in motivated volunteers with type 2 diabetes. The diet lower in carbohydrate led to greater improvements in glycemic control, and more frequent medication reduction/elimination than the low glycemic index diet. Lifestyle modification using low carbohydrate interventions is effective for improving and reversing type 2 diabetes.

A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial - PubMedCompared with a low-fat diet, a low-carbohydrate diet program had better participant retention and greater weight loss. During active weight loss, serum triglyceride levels decreased more and high-density lipoprotein cholesterol level increased more with the low-carbohydrate diet than with the low-f …

Effect of 6-month adherence to a very low carbohydrate diet programTo determine the effect of a 6-month very low carbohydrate diet program on body weight and other metabolic parameters.

Can low-carbohydrate diets be recommended for reducing... : Current Opinion in Endocrinology, Diabetes and Obesityings Type 2 diabetes mellitus (T2DM), metabolic syndrome, and related co-morbidities are major risk factors for cardiovascular disease (CVD). Ideally, then, a diet intended to support cardiovascular health should be one that improves or reverses these underlying risk factors. Carbohydrate restriction is effective for this purpose as well as for favorably impacting atherogenic dyslipidemia. Recent consensus reports from select national organizations have endorsed low-carbohydrate diets for improving glycemia and cardiovascular risk. Reluctance among public health organizations and some clinicians to more widely promote this therapeutic nutritional approach is driven primarily by the increase in serum low-density lipoprotein cholesterol (LDL-C) observed in a proportion of individuals who adopt a low-carbohydrate diet. Here we explore the rationale for using carbohydrate restriction to improve cardiovascular health by way of favorably impacting T2DM and insulin resistance, and why this salutary effect outweighs the potential adverse effects of an increase in serum LDL-C. Summary Carbohydrate restriction is a logical foundation for a dietary intervention intended to reduce CVD risk, particularly among individuals with T2DM or metabolic syndrome....

Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal - Nutrition & MetabolismCurrent nutritional approaches to metabolic syndrome and type 2 diabetes generally rely on reductions in dietary fat. The success of such approaches has been limited and therapy more generally relies on pharmacology. The argument is made that a re-evaluation of the role of carbohydrate restriction, the historical and intuitive approach to the problem, may provide an alternative and possibly superior dietary strategy. The rationale is that carbohydrate restriction improves glycemic control and reduces insulin fluctuations which are primary targets. Experiments are summarized showing that carbohydrate-restricted diets are at least as effective for weight loss as low-fat diets and that substitution of fat for carbohydrate is generally beneficial for risk of cardiovascular disease. These beneficial effects of carbohydrate restriction do not require weight loss. Finally, the point is reiterated that carbohydrate restriction improves all of the features of metabolic syndrome.

Editorial: Carbohydrate-Restricted Nutrition and Diabetes MellitusInsulin resistance is characterized by elevated insulin levels. The most commonly used approaches to treat conditions caused by insulin resistance, including Type 2 Diabetes (T2DM), involves medications. The management of insulin resistance with medications then typically leads to a need for "intensification of medications" to improve glycemic control.(1) However, giving medications like insulin to treat insulin resistance and/or T2DM does not cure these conditions-it perpetuates or even worsens the insulin resistance. This consequence is especially likely if medication treatment leads to weight gain, because weight gain leads to a worsening of the insulin resistance. A alternative approach to the treatment of insulin resistance is to use strategies that lower insulin blood levels, including non-pharmacologic treatments.Obesity Medicine is a medical subspecialty that treats T2DM by targeting underlying contributors of insulin resistance and T2DM: obesity and lifestyle. One of the lifestyle approaches used by obesity medicine specialists is a carbohydrate-restricted diet.(2) Several studies have shown that a carbohydrate-restricted diet can lead to improvements and even reversal of T2DM. (3,4) Because many barriers exist to the implementation of carbohydrate-restricted diets into medical practice, this Special Issue invited articles related to the use of carbohydrate-restriction for T2DM. In this issue, the paper topics range from theoretical to practical aspects of the use...

Implementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus - PubMedWhile the current treatment of T2DM emphasizes drug treatment and a higher carbohydrate diet, the ketogenic diet is an effective alternative that relies less on medication, and may even be a preferable option when medications are not available.

A review of low-carbohydrate ketogenic diets - Current Atherosclerosis ReportsIn response to the emerging epidemic of obesity in the United States, a renewal of interest in alternative diets has occurred, especially in diets that limit carbohydrate intake. Recent research has demonstrated that low-carbohydrate ketogenic diets can lead to weight loss and favorable changes in serum triglycerides and high-density lipoprotein cholesterol. This review summarizes the physiology and recent clinical studies regarding this type of diet.

The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 InpatientsBackground and HypothesisThe robust evidence base supporting the therapeutic benefit of ketogenic diets in epilepsy and other neurological conditions suggests this same metabolic approach may also benefit psychiatric conditions.Study DesignIn this retrospective analysis of clinical care, 31 adults with severe, persistent mental illness (major depressive disorder, bipolar disorder, and schizoaffective disorder) whose symptoms were poorly controlled despite intensive psychiatric management were admitted to a psychiatric hospital and placed on a ketogenic diet restricted to a maximum of 20 grams of carbohydrate per day as an adjunct to conventional inpatient care. The duration of the intervention ranged from 6 to 248 days.Study ResultsThree patients were unable to adhere to the diet for >14 days and were excluded from the final analysis. Among included participants, means and standard deviations (SDs) improved for the Hamilton Depression Rating Scale scores from 25.4 (6.3) to 7.7 (4.2), P < 0.001 and the Montgomery-Åsberg Depression Rating Scale from 29.6 (7.8) to 10.1 (6.5), P < 0.001. Among the 10 patients with schizoaffective illness, mean (SD) of the Positive and Negative Syndrome Scale (PANSS) scores improved from 91.4 (15.3) to 49.3 (6.9), P < 0.001. Significant improvements were also observed in metabolic health measures including weight, blood pressure, blood glucose, and triglycerides.ConclusionsThe administration of a ketogenic diet in this semi-controlled setting t...

Dietary treatment of diabetes mellitus in the pre-insulin era (1914-1922) - PubMedBefore the discovery of insulin, one of the most common dietary treatments of diabetes mellitus was a high-fat, low-carbohydrate diet. A review of Frederick M. Allen's case histories shows that a 70% fat, 8% carbohydrate diet could eliminate glycosuria among hospitalized patients. A reconsideration …

Type 2 Diabetes Mellitus: A Pathophysiologic PerspectiveType 2 Diabetes Mellitus (T2DM) is characterized by chronically elevated blood glucose (hyperglycemia) and elevated blood insulin (hyperinsulinemia). When the blood glucose concentration is 100 milligrams/deciliter the bloodstream of an average adult ...

LCHF/IF RESOURCES | MAIN PAGE

LCHF/IF | EXPERTS/ADVOCATES

Google Sites

Report abuse